1. Home
  2. VVOS vs BGLC Comparison

VVOS vs BGLC Comparison

Compare VVOS & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVOS
  • BGLC
  • Stock Information
  • Founded
  • VVOS 2016
  • BGLC 2017
  • Country
  • VVOS United States
  • BGLC Malaysia
  • Employees
  • VVOS N/A
  • BGLC N/A
  • Industry
  • VVOS Medical Specialities
  • BGLC Medical Specialities
  • Sector
  • VVOS Health Care
  • BGLC Health Care
  • Exchange
  • VVOS Nasdaq
  • BGLC Nasdaq
  • Market Cap
  • VVOS 11.9M
  • BGLC 7.6M
  • IPO Year
  • VVOS 2020
  • BGLC N/A
  • Fundamental
  • Price
  • VVOS $2.70
  • BGLC $0.37
  • Analyst Decision
  • VVOS Strong Buy
  • BGLC
  • Analyst Count
  • VVOS 1
  • BGLC 0
  • Target Price
  • VVOS $6.60
  • BGLC N/A
  • AVG Volume (30 Days)
  • VVOS 136.1K
  • BGLC 70.7K
  • Earning Date
  • VVOS 11-15-2024
  • BGLC 11-20-2024
  • Dividend Yield
  • VVOS N/A
  • BGLC N/A
  • EPS Growth
  • VVOS N/A
  • BGLC N/A
  • EPS
  • VVOS N/A
  • BGLC N/A
  • Revenue
  • VVOS $14,021,000.00
  • BGLC $9,183,168.00
  • Revenue This Year
  • VVOS $17.56
  • BGLC N/A
  • Revenue Next Year
  • VVOS $31.31
  • BGLC N/A
  • P/E Ratio
  • VVOS N/A
  • BGLC N/A
  • Revenue Growth
  • VVOS N/A
  • BGLC N/A
  • 52 Week Low
  • VVOS $1.91
  • BGLC $0.31
  • 52 Week High
  • VVOS $48.79
  • BGLC $3.39
  • Technical
  • Relative Strength Index (RSI)
  • VVOS 45.52
  • BGLC 38.31
  • Support Level
  • VVOS $2.62
  • BGLC $0.36
  • Resistance Level
  • VVOS $2.99
  • BGLC $0.39
  • Average True Range (ATR)
  • VVOS 0.20
  • BGLC 0.02
  • MACD
  • VVOS 0.02
  • BGLC -0.00
  • Stochastic Oscillator
  • VVOS 22.95
  • BGLC 21.74

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.

Share on Social Networks: